Add to ORKGand low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762. Physicians ’ Health Study (PHS): Steering Committee of the Physicians ' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians ' Health Study. N.Engl.J.Med. 1989; 321: 129-135. Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin an
Aspirin reduces the risk of non-fatal stroke, non-fatal myocardial infarction and vascular death in ...
• In patients with a history of cardiovascular disease (CVD), aspirin therapy reduces the risk of se...
Objectives of the study: The main objective of the study is to find the effect of oral antihypertens...
BACKGROUND: Despite treatment, there is often a higher incidence of cardiovascular complications in ...
Background Despite treatment, there is often a higher incidence of cardiovascular complications in p...
Background Despite treatment, there is often a higher incidence of cardiovascular complications in p...
OBJECTIVE: The Hypertension Optimal Treatment (HOT) study is a large, prospective trial aimed at def...
OBJECTIVE: The Hypertension Optimal Treatment (HOT) study is a large, prospective trial aimed at def...
Aspirin is now a useful therapy for both primary and secondary prevention for cardiovascular events ...
The Hypertension Optimal Treatment Study is a prospective trial conducted in 26 countries. The aims ...
Contains fulltext : 80426.pdf (Publisher’s version ) (Open Access)RU Radboud Unive...
The HOT study (hypertension-optimal treatment) is an international clinical study on primary prevent...
Aspirin at low doses is used as an inhibitor of platelet aggregation and is frequently administered ...
The Physicians' Health Study is a randomized, double-blind, placebo-controlled trial that studied lo...
Low-dose aspirin (75 – 325 mg per day) is widely used in the prevention of myocardial infarction or ...
Aspirin reduces the risk of non-fatal stroke, non-fatal myocardial infarction and vascular death in ...
• In patients with a history of cardiovascular disease (CVD), aspirin therapy reduces the risk of se...
Objectives of the study: The main objective of the study is to find the effect of oral antihypertens...
BACKGROUND: Despite treatment, there is often a higher incidence of cardiovascular complications in ...
Background Despite treatment, there is often a higher incidence of cardiovascular complications in p...
Background Despite treatment, there is often a higher incidence of cardiovascular complications in p...
OBJECTIVE: The Hypertension Optimal Treatment (HOT) study is a large, prospective trial aimed at def...
OBJECTIVE: The Hypertension Optimal Treatment (HOT) study is a large, prospective trial aimed at def...
Aspirin is now a useful therapy for both primary and secondary prevention for cardiovascular events ...
The Hypertension Optimal Treatment Study is a prospective trial conducted in 26 countries. The aims ...
Contains fulltext : 80426.pdf (Publisher’s version ) (Open Access)RU Radboud Unive...
The HOT study (hypertension-optimal treatment) is an international clinical study on primary prevent...
Aspirin at low doses is used as an inhibitor of platelet aggregation and is frequently administered ...
The Physicians' Health Study is a randomized, double-blind, placebo-controlled trial that studied lo...
Low-dose aspirin (75 – 325 mg per day) is widely used in the prevention of myocardial infarction or ...
Aspirin reduces the risk of non-fatal stroke, non-fatal myocardial infarction and vascular death in ...
• In patients with a history of cardiovascular disease (CVD), aspirin therapy reduces the risk of se...
Objectives of the study: The main objective of the study is to find the effect of oral antihypertens...